Rahul Singhvi
Direktor/Vorstandsmitglied bei CODEXIS, INC.
Vermögen: 324 713 $ am 31.05.2024
Aktive Positionen von Rahul Singhvi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CODEXIS, INC. | Direktor/Vorstandsmitglied | 28.09.2022 | - |
| Independent Dir/Board Member | 28.09.2022 | - | |
Swiftscale Biologics, Inc.
 Swiftscale Biologics, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Swiftscale Biologics, Inc. develops protein synthesis technologies. The company is based in La Jolla, CA. The company was founded in 2018 by Michael Jewett, Matthew DeLisa. The CEO is Rahul Singhvi. Swiftscale Biologics was acquired by National Resilience, Inc. on December 02, 2021. | Vorstandsvorsitzender | - | - |
Resilience Biotechnologies, Inc.
 Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the company is Rahul Singhvi. | Vorstandsvorsitzender | - | - |
Garuda Therapeutics, Inc.
 Garuda Therapeutics, Inc. BiotechnologyHealth Technology Garuda Therapeutics, Inc. aims to eliminate the need for donor or patient cells for blood stem cell transplants. The company is based in Natick, MA. The company's platform technology generates off-the-shelf, self-renewing blood stem cells that are HLA-compatible and transgene-free. This technology could potentially provide curative therapies for over 120 diseases. Garuda Therapeutics was founded by Dhvanit Shah, Sean Morrison, and David T. Scadden, with Dhvanit Shah serving as CEO since incorporation. | Direktor/Vorstandsmitglied | - | - |
National Resilience, Inc.
 National Resilience, Inc. Miscellaneous Commercial ServicesCommercial Services National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA. | Direktor/Vorstandsmitglied | 01.01.2020 | - |
| Vorstandsvorsitzender | 01.01.2020 | - | |
| Gründer | 01.01.2020 | - | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Präsident | 01.12.2019 | - |
| Axella Solutions LLC | Gründer | - | - |
| Corporate Officer/Principal | - | - | |
| Keck Graduate Institute of Applied Life Sciences | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Rahul Singhvi
Ehemalige bekannte Positionen von Rahul Singhvi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Corporate Officer/Principal | 01.10.2019 | 01.07.2020 |
| ░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | ░░░░░░░░░░ |
| ░░░░░ ░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░░░ ░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░ ░░░░░░░ ░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Rahul Singhvi
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Indian Institute of Technology Kanpur | Undergraduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 20 |
| Indien | 2 |
| Belgien | 2 |
Operativ
| Director/Board Member | 8 |
| Corporate Officer/Principal | 6 |
| Chief Executive Officer | 4 |
Sektoral
| Health Technology | 11 |
| Consumer Services | 4 |
| Finance | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NOVAVAX, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| CODEXIS, INC. | Process Industries |
| Private Unternehmen | 15 |
|---|---|
Magnum Hunter Resources, Inc.
 Magnum Hunter Resources, Inc. Integrated OilEnergy Minerals Magnum Hunter Resources, Inc. provides oil exploration and drilling services. The company is headquartered in Irving, TX | Energy Minerals |
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ. | Health Technology |
| Axella Solutions LLC | |
Bill, Hillary & Chelsea Clinton Foundation
 Bill, Hillary & Chelsea Clinton Foundation Services to the Health IndustryHealth Services Bill, Hillary & Chelsea Clinton Foundation engages in the provision of emergency relief services. It focuses on worldwide issues that demand urgent action, solutions and measurable results - global climate change, Human Immune deficiency/ Acquired Immune Deficiency Syndrome in the developing world, childhood obesity and economic opportunity in the United States and economic development in Africa and Latin America. The company was founded by William Jefferson Clinton in September 2005 and is headquartered in New York, NY. | Health Services |
Caliber Biotherapeutics LLC
 Caliber Biotherapeutics LLC Pharmaceuticals: MajorHealth Technology Caliber Biotherapeutics LLC. develops and commercializes protein-based therapeutics that improve outcomes for patients with cancer and other diseases. Its products include CBD Oil, CBD Vape Liquid, CBD Edibles, CBD Crystals, and CBD capsules. The company was founded on July 31, 2009 and is headquartered in Dallas, TX. | Health Technology |
NewGen BioPharma Corp. /Old/
 NewGen BioPharma Corp. /Old/ Pharmaceuticals: MajorHealth Technology NewGen BioPharma Corp. provides biopharmaceutical products. It develops and commercializes pharmaceuticals and cosmaceuticals through reformulating approved API’s (Active Pharmaceutical Ingredients) using multiple proprietary nanotechnology platforms including the Micellar Nano Particle (MNP) platform. The company was founded by Navdeep S. Jaikaria and is headquartered in Titusville, NJ. | Health Technology |
Univercells SA
 Univercells SA BiotechnologyHealth Technology Univercells SA designs single-use cost-efficient bioprocess solutions to open the next chapter in bio manufacturing. The company was founded by Jose Castillo, Guillaume De Viron and Hugues Bultot in 2013 and is headquartered in Gosselies, Belgium. | Health Technology |
Takeda Vaccines, Inc.
 Takeda Vaccines, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Vaccines, Inc. provides biological research and development services. The company is based in Bozeman, MT. | Commercial Services |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Health Technology |
National Resilience, Inc.
National Resilience, Inc. Miscellaneous Commercial ServicesCommercial Services National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA. | Commercial Services |
Garuda Therapeutics, Inc.
Garuda Therapeutics, Inc. BiotechnologyHealth Technology Garuda Therapeutics, Inc. aims to eliminate the need for donor or patient cells for blood stem cell transplants. The company is based in Natick, MA. The company's platform technology generates off-the-shelf, self-renewing blood stem cells that are HLA-compatible and transgene-free. This technology could potentially provide curative therapies for over 120 diseases. Garuda Therapeutics was founded by Dhvanit Shah, Sean Morrison, and David T. Scadden, with Dhvanit Shah serving as CEO since incorporation. | Health Technology |
Resilience Biotechnologies, Inc.
Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the company is Rahul Singhvi. | Health Technology |
Swiftscale Biologics, Inc.
Swiftscale Biologics, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Swiftscale Biologics, Inc. develops protein synthesis technologies. The company is based in La Jolla, CA. The company was founded in 2018 by Michael Jewett, Matthew DeLisa. The CEO is Rahul Singhvi. Swiftscale Biologics was acquired by National Resilience, Inc. on December 02, 2021. | Health Technology |
| Valor Biotherapeutics LLC | |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
- Börse
- Insiders
- Rahul Singhvi
- Erfahrung
